PAK signalling influences endothelial behaviour and immune functions [13]; however, the specific roles of PAK1 or PAK4 in vascular reprogramming, hypoxia, and the gemcitabine response have not been fully addressed in pancreatic cancer. This evidence concerns the gene PAK1 and pancreatic neoplasm.